Drugs and Devices

FDA approves new drug for PAH

On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH). Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares